Markets

Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week

By CNBC Mar 27, 2026 1 min read 2 views

The Swiss pharma giant is betting on a next-generation allergy treatment that may prove to work faster and better than anything currently on the market.

Markets

Gainers & Losers: Adani Green and HDFC Bank among 9 big movers on Wednesday

Markets rallied after Donald Trump announced a two week pause, boosting sentiment across sectors. Ni...

The Big Review: Markets near bottom, selective opportunities emerging for FY27

HDFC Securities report highlights India’s macro stability despite global risks, with steady growth...

Markets may be entering opportunity phase; focus on selective bets: Dhiraj Relli

Dhiraj Relli warns elevated crude prices may impact inflation, rates and earnings amid global uncert...

US Stocks today: Dow Jones rockets 1,300 pts, S&P 500 up 2%, Nasdaq 3% after US-Iran ceasefire

Wall Street's main indexes opened higher on Wednesday after the U.S. and Iran ‌agreed ⁠...

Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week

Related Articles

Gainers &amp; Losers: Adani Green and HDFC Bank among 9 big movers on Wednesday

The Big Review: Markets near bottom, selective opportunities emerging for FY27

Markets may be entering opportunity phase; focus on selective bets: Dhiraj Relli

US Stocks today: Dow Jones rockets 1,300 pts, S&amp;P 500 up 2%, Nasdaq 3% after US-Iran ceasefire

Gainers & Losers: Adani Green and HDFC Bank among 9 big movers on Wednesday

US Stocks today: Dow Jones rockets 1,300 pts, S&P 500 up 2%, Nasdaq 3% after US-Iran ceasefire